Literature DB >> 20688961

Dasatinib, an immunomodulator?

Farhad Ravandi1.   

Abstract

Entities:  

Year:  2010        PMID： 20688961     DOI： 10.1182/blood-2010-05-283127

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  2 in total

Review 1.  Biological therapy and the immune system in patients with chronic myeloid leukemia.

Authors:  Peter Rohon
Journal:  Int J Hematol       Date:  2012-06-04       Impact factor: 2.490

2.  Rapid and sustained increase of large granular lymphocytes and rare cytomegalovirus reactivation during dasatinib treatment in chronic myelogenous leukemia patients.

Authors:  Hideo Tanaka; Shizuka Nakashima; Miyuki Usuda
Journal:  Int J Hematol       Date:  2012-07-06       Impact factor: 2.490
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.